FIELD: medicine.
SUBSTANCE: invention concerns medicine and biology, particularly biophysical methods of blood examination methods, and can be applied in diagnostics of toxic heavy metal effect caused by environmental pollution, and human health assessment, for pregnant women as well. The method involves extraction of 0.02 ml of capillary blood for examination, placing it into cooled mix of 0.5 ml of 0.15 M phosphate poiser with pH=7.4 and 0.5 ml of 0.25% glutaric aldehyde solution at the ratio of 1:1, resuspension by placing the mix to refrigerator at the temperature of 4°C for 60 min for cell form fixation. Then, after the fixation, the test tube content is resuspended again, 0.01 ml of cell suspension is placed onto the object glass, 250 cells are selected, number of discocytes in native preparation is defined, followed by careful stirring of the left cell suspension. 0.08 ml of cooled-down cell suspension is poured into four test tubes: to one test tube 0.02 ml of 0.01% ZnSO4 solution is added, to another - 0.02 ml of 0.1% MnSO4, to the third - 0.02 ml of 0.005% NiSO4 solution, to the fourth - 0.02 ml of 0.01% Pb(NO3)2, and all four are incubated at the room temperature of 18-20°C for 30 minutes, After incubation the test tube content is resuspended again, 0.01 ml of cell suspension is placed onto objective glass, 250 cells are selected, number of discocytes and erythrocyte membrane susceptibility are defined by the formula: , where Kmp is the erythrocyte membrane susceptibility index; Dn is the number of discocytes in native smear, %; Dm is the number of discocytes left under the influence of given heavy metals, %; and if Kmp is under 95% of the original level, then the cell membranes are susceptible to the respective heavy metal.
EFFECT: possibility for early pre-clinical diagnostics of pathology related to heavy metal effect.
3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETERMINATION OF MANGANESE TOXICITY IN CHILDREN BEING RESIDENTS OF TECHNOGENICALLY-LOADED TERRITORIES | 2010 |
|
RU2437095C1 |
METHOD FOR IDENTIFYING ANTIGEN/HAPTEN-SPECIFIC IMMUNOCOMPETENT BLOOD CELLS SUBPOPULATIONS | 1997 |
|
RU2128841C1 |
METHOD FOR DETERMINING STAGE OF IRON DEFICIENCY | 2012 |
|
RU2518316C2 |
METHOD FOR TREATING IODINE-DEFICIENT STATES IN PREGNANT WOMEN | 2004 |
|
RU2275922C2 |
METHOD OF INSULIN RESISTANCE TESTING FOR FIRST-TYPE DIABETIC PATIENTS | 0 |
|
SU1762241A1 |
METHOD FOR PERIPHERAL BLOOD ERYTHROCYTE GLUTATHIONE TEST | 2013 |
|
RU2526832C1 |
METHOD OF DETERMINING INSULIN RESISTANCE OF IMMUNOGENESIS IN PATIENTS WITH TYPE 1 DIABETES MELLITUS | 0 |
|
SU1767433A1 |
METHOD OF DETERMINING UNSATURATED FATTY ACIDS IN PERIPHERAL BLOOD ERYTHROCYTES | 2015 |
|
RU2592239C1 |
METHOD OF VIRAL HERPES GESTATIONIS DIAGNOSTICS BY HERPES BODIES ESTIMATION IN PERIPHERAL BLOOD | 2006 |
|
RU2330286C1 |
METHOD OF DIAGNOSING | 1997 |
|
RU2128340C1 |
Authors
Dates
2008-08-27—Published
2006-12-18—Filed